Isabella Robinson, APRN
Primary Care · Hermitage, TNNPI 1790554897
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novo Nordisk at 38.4% of the total.
Across 133 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$385
- Astellas Pharma US Inc$342
- Pfizer$187
- Boehringer Ingelheim$172
- Exact Sciences$162
- plus $378 from 11 others
What the payments were for
- Food & beverage$2,642100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $1,015 |
| AstraZeneca(2 entities) | 21 | $385 |
| Astellas Pharma US Inc | 17 | $342 |
| Pfizer | 11 | $187 |
| Boehringer Ingelheim | 9 | $172 |
| Exact Sciences | 9 | $162 |
| AbbVie | 5 | $125 |
| Cequr Corporation | 1 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Smith+Nephew | 1 | $27 |
| Bayer | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Boston Scientific | 1 | $23 |
| IBSA Pharma Inc. | 1 | $15 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
How this compares
$2,642 in reported general payments places this provider in the 80th percentile of 189 primary care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 50 | $877 |
| Rosuvastatin Calcium | 21 | $423 |
| ClopidogrelClopidogrel Bisulfate | 15 | $391 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $382 |
| Atorvastatin Calcium | 27 | $368 |
| Pantoprazole Sodium | 21 | $355 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 29 | $340 |
| Cefdinir | 21 | $278 |
| Levothyroxine Sodium | 16 | $234 |
| Fluticasone Propionate | 27 | $231 |
| Tamsulosin Hcl | 14 | $164 |
| Montelukast Sodium | 13 | $146 |
| Potassium Chloride | 23 | $141 |
| Azithromycin | 31 | $139 |
| Furosemide | 41 | $133 |
Paid to pharmacies, not to this prescriber.
Other primary care in Hermitage
- Mary SullivanGermantown$115K
- Len GetzMemphis$25K
- Judith CaldwellNashville$18K
- Mara HutchingsNashville$14K
- Reena BhaktaMurfreesboro$12K
- Ryan HartmanNashville$11K
- Martha LemonsBrentwood$11K
- Abigail EubankHendersonville$9K
- Corey ClelandSevierville$9K
- Katie JohnsonClarksville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.